Mulmit

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-316,000-6,142,814-5,995,008-2.52
2024-12-3111,000-5,743,861-5,493,481-3.71
2023-12-319,000-5,620,132-5,286,574-3.76
2022-12-3188,600-10,244,372-10,144,044-0.93
2021-12-3187,754-3,125,94919,211,7685.61

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2025-02-19Finger Michael H.750
2025-02-18Finger Michael H.750
2023-06-28Warbington TimothyPresident & CEO200
2023-06-27Warbington TimothyPresident & CEO300
2023-06-27Warbington TimothyPresident & CEO300
2023-06-27Warbington TimothyPresident & CEO200
2022-11-22Warbington TimothyPresident & CEO9,800
2022-11-22Warbington TimothyPresident & CEO200
2022-11-21Warbington TimothyPresident & CEO10,000
2022-11-21Warbington TimothyPresident & CEO5,000
2022-09-27Finger Michael H.2,000
2022-09-27Warbington TimothyPresident & CEO20,000

8-K events

FiledItems
2026-08-31Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-07-02Entry into a material agreement · Unregistered sales of equity securities · Officer or director change · Financial statements and exhibits
2025-12-31Submission of matters to a vote · Financial statements and exhibits
2025-12-19Submission of matters to a vote · Financial statements and exhibits
2025-11-12Officer or director change · Financial statements and exhibits
2025-10-31Entry into a material agreement · Unregistered sales of equity securities · Financial statements and exhibits
2025-05-06Submission of matters to a vote · Financial statements and exhibits
2025-04-11Delisting or listing-standard notice · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.